These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2030367)

  • 21. Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
    Wakata N; Nemoto H; Sugimoto H; Nomoto N; Konno S; Hayashi N; Araki Y; Nakazato A
    Clin Neurol Neurosurg; 2004 Mar; 106(2):139-41. PubMed ID: 15003307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis.
    Kim YH; Shin HY; Kim SM
    Yonsei Med J; 2019 Jul; 60(7):633-639. PubMed ID: 31250577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term administration of corticosteroids in myasthenia gravis.
    Mann JD; Johns TR; Campa JF
    Neurology; 1976 Aug; 26(8):729-40. PubMed ID: 821005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results of corticosteroid therapy in patients with myasthenia gravis.
    Evoli A; Batocchi AP; Palmisani MT; Lo Monaco M; Tonali P
    Eur Neurol; 1992; 32(1):37-43. PubMed ID: 1563453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term therapeutic efficacy and safety of low-dose tacrolimus (FK506) for myasthenia gravis.
    Tada M; Shimohata T; Tada M; Oyake M; Igarashi S; Onodera O; Naruse S; Tanaka K; Tsuji S; Nishizawa M
    J Neurol Sci; 2006 Aug; 247(1):17-20. PubMed ID: 16631797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative low-dose steroid can prevent respiratory insufficiency after thymectomy in generalized myasthenia gravis.
    Kataoka H; Kiriyama T; Kawaguchi T; Sawa N; Sugie K; Horikawa H; Tojo T; Ueno S
    Eur Neurol; 2014; 72(3-4):228-33. PubMed ID: 25247848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of IL-6 overproduction by steroid treatment before transsternal thymectomy for myasthenia gravis: does it help stabilize perioperative condition?
    Endo S; Hasegawa T; Sato Y; Otani S; Saito N; Tetsuka K; Tezuka Y; Sohara Y
    Eur J Neurol; 2005 Oct; 12(10):768-73. PubMed ID: 16190914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized Trial of Thymectomy in Myasthenia Gravis.
    Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BR; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Garcia Ramos GS; Verschuuren JJ; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Odenkirchen J; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
    N Engl J Med; 2016 Aug; 375(6):511-22. PubMed ID: 27509100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intermittent methylprednisolone pulse therapy for myasthenia gravis in childhood].
    Tanaka J; Matsuzaki K; Arai H; Nagai T; Matsumoto Y; Okada S
    No To Hattatsu; 1994 Jan; 26(1):14-9. PubMed ID: 8280441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis and surgical treatment of myasthenia gravis in childhood].
    Vetshev PS; Shkrob OS; Zaĭrat'iants OV; Ippolitov IKh; Shagal DI; Chilingaridi KE; Kurochkin AV
    Khirurgiia (Mosk); 1991 Dec; (12):74-80. PubMed ID: 1803128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenetic therapy of diseases of the nervous system and muscles with large doses of prednisolone on alternate days.
    Gekht BM; Kuzin MI; Kolomenskaya EA; Gnezditskaya EV; Zefirova GS; Ibragimova GV; Ippolitov IK; Kuralesin MG; Polykovskaya ID; Shagal DI
    Neurosci Behav Physiol; 1981; 11(4):363-6. PubMed ID: 7343875
    [No Abstract]   [Full Text] [Related]  

  • 32. Alopecia areata associated with myasthenia gravis and thymoma: a case of alopecia with marked improvement following thymectomy and high level prednisolone administration.
    Kamada N; Hatamochi A; Shinkai H
    J Dermatol; 1997 Dec; 24(12):769-72. PubMed ID: 9492440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Status of the hypophysis-adrenal cortex system during treatment with glucocorticoids by the method of intermittent (every other day) administration].
    Zefirova GS; Ibragimova GV; Beĭsugurov MSh; Shmushkovich BI
    Ter Arkh; 1986; 58(10):114-7. PubMed ID: 3026061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma pyridostigmine levels in myasthenia gravis.
    White MC; De Silva P; Havard CW
    Neurology; 1981 Feb; 31(2):145-50. PubMed ID: 7193298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of myasthenia gravis. Report on 139 patients.
    Scoppetta C; Tonali P; Evoli A; David P; Crucitti F; Vaccario ML
    J Neurol; 1979; 222(1):11-21. PubMed ID: 93623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Massive prednisolone administration in myasthenia gravis--electrophysiological examination].
    Yanagizawa N; Shoji S; Tsukagoshi H; Toyokura Y
    Nihon Rinsho; 1973 Feb; 31(2):321-6. PubMed ID: 4737112
    [No Abstract]   [Full Text] [Related]  

  • 37. [A case of myasthenia gravis, who developed minimal change nephrotic syndrome during immunosuppressive therapy after thymectomy].
    Takahashi K; Inoue Y; Matsuda O; Takemura T; Yoshimura A
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):394-8. PubMed ID: 10998921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term treatment of generalised myasthenia gravis with FK506 (tacrolimus).
    Konishi T; Yoshiyama Y; Takamori M; Saida T
    J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):448-50. PubMed ID: 15716549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic strategies against myasthenia gravis].
    Utsugisawa K; Nagane Y
    Nihon Rinsho; 2013 May; 71(5):881-6. PubMed ID: 23777099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of myasthenia gravis: a comparison of the natural course and current therapies.
    Seto M; Motomura M; Takeo G; Yoshimura T; Tsujihata M; Nagataki S
    Tohoku J Exp Med; 1993 Jan; 169(1):77-86. PubMed ID: 8211972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.